A new class of superdrug invented by an Australian scientist could prevent cancer, Alzheimer's disease.
What's more, Professor David Sinclair said that his drugs have the potential to help some people enjoy a healthy life until the age of 150. However, this needs further research.
Alzheimers Disease
Alzheimer''s disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
Advertisement
The researcher explains how the drugs have the ability to switch on the body's defenses against ageing, News.com.au reported.
Three of the drugs are in human trials for the treatment of specific illnesses such as type 2 diabetes and inflammatory bowel disease, the University of New South Wales geneticist said.
![Quiz on Cancer]( "Quiz on Cancer")
Cancer, is the second most leading cause of death worldwide. Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Take this quiz on and test how much you know about cancer.
Prof Sinclair is most excited about the potential to prevent illness and hopes to prove the drugs will have a dual purpose of treating and preventing disease at the same time.
"My research has been criticised because it sounds too good to be true. This paper shows it is true," he said in a telephone interview from Harvard Medical School, where he is based.
Prof Sinclair's drugs target the enzyme SIRT1, which is switched on naturally by calorie restriction and exercise, but it can also be enhanced through activators such as resveratrol in red wine.
He and his colleagues have developed 4000 synthetic activators.
Each one is 100 times more potent than a glass of red wine and the best three are the ones in human trials.
Prof Sinclair suggests the first medicine to be marketed could be for diabetes in about five years.
Once a significant number of people are using the drugs, it will be possible to assess other benefits.
In animal tests, overweight mice given synthetic resveratrol were able to run twice as far as slim mice and they lived 15 per cent longer.
The findings are published in the journal Science.
Source: ANI
Quiz on Cancer
Cancer, is the second most leading cause of death worldwide. Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Take this quiz on and test how much you know about cancer.
Advertisement
Prof Sinclair is most excited about the potential to prevent illness and hopes to prove the drugs will have a dual purpose of treating and preventing disease at the same time.
"My research has been criticised because it sounds too good to be true. This paper shows it is true," he said in a telephone interview from Harvard Medical School, where he is based.
Prof Sinclair's drugs target the enzyme SIRT1, which is switched on naturally by calorie restriction and exercise, but it can also be enhanced through activators such as resveratrol in red wine.
He and his colleagues have developed 4000 synthetic activators.
Each one is 100 times more potent than a glass of red wine and the best three are the ones in human trials.
Prof Sinclair suggests the first medicine to be marketed could be for diabetes in about five years.
Once a significant number of people are using the drugs, it will be possible to assess other benefits.
In animal tests, overweight mice given synthetic resveratrol were able to run twice as far as slim mice and they lived 15 per cent longer.
The findings are published in the journal Science.
Source: ANI
World Cancer Death Clock
World Cancer Death Clock is a dynamic calculator that constantly updates the number of people in the world dying due to various cancers.
Advertisement
 Caring for Alzheimers disease patientsAlzheimer's disease is a complex brain disorder that triggers the most common form of dementia. The slide show will show how patients need support and care as dementia progresses. | Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
